Medical/Pharmaceuticals

BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors

HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY inSan Antonio, Texas.

2019-12-09 21:00 1537

CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody

SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company committed to discovering and developing a combined platform of Chimeric Antigen Receptor T (CAR-T) cell therapies and monoclonal antibodies for cancer, today announced that one of its leading d...

2019-12-09 18:00 3349

Korean ophthalmologist Oh Jungwoo performed '25 sec LASEK' in public for the first time

SEOUL, South Korea, Dec. 6, 2019 /PRNewswire/ -- Dr. Oh Jungwoo from Eos Eye Center in Gangnam-gu, Korea, revealed '25 sec LASEK' surgery publicly by video. This is the first time the operation has been released to the public and it shows Dr. Oh's surgery on a patient's left eye with minimal corn...

2019-12-06 22:00 1340

Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK) one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck KGaA, Darmstadt,Germany, a leading science a...

2019-12-04 16:01 5938

United Imaging, BAMF Health Bring Bold Vision to Life: Global Strategic Partnership Advances Theranostics and Precision Medicine

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enabled precision medicine through molecular imaging and theranostic...

2019-12-03 21:00 1059

Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain...

2019-12-03 17:36 1115

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * NERLYNX is the first therapy in the Specialised Therapeutics' portfolio approved inSE Asia * Five-year follow up data show NERLYNX reduces risk of invasive disease...

2019-12-03 05:30 1198

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:18 1351

Concord Medical Announces Changes to the Board

BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced the resignation of Mr. Sha...

2019-12-02 17:39 5484

Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics (01801.HK), a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal anti...

2019-12-02 09:37 5281

United Imaging Sends a Big Message with New Launches, Collaborations

HOUSTON, Dec. 1, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has begun unveiling new technology and strategic collaborations that showcase significant commitment to U.S. market growth. The company had already announced an agreement...

2019-12-02 02:30 1765

Concord Medical Schedules 2019 Annual Meeting of Shareholders

BEIJING, Nov. 28, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that it will hold its 201...

2019-11-28 17:30 6400

VUNO Presents the Future of Medical AI Solutions at RSNA 2019

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution developer and a member company of the Born2Global Centre, will participate in  RSNA (Radiological Society ofNorth America) 2019 in Chicago, December 1-8. Booth: North Hall Level2, #11132.

2019-11-27 21:30 1762

Venturing into the future of healthcare with AI - SonoScape at Medica 2019

DUSSELDORF, Germany, Nov. 25, 2019 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, presented its latest products and technologies in the world's largest medical event Medica: its first echoendoscope EG-UR5 (endoscopic ultrasound), a new 4-...

2019-11-25 20:28 1691

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of18F -APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer's Disease (AD). The study (NCT number: NCT04141150) w...

2019-11-21 23:00 1547

Seed Health Announces Research Partnership with Atmo Biosciences to Evaluate Impact of Probiotics With First Ingestible Gas Sensor Technology

First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- Seed Health, a microbial sciences company, today announced a research partnership with digital health company, At...

2019-11-21 21:00 1304

Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park

SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...

2019-11-21 11:30 1702

Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing

ZHENGZHOU, Nov. 19, 2019 /PRNewswire/ -- Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. ("Burning Rock Dx") jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR i...

2019-11-19 21:00 1492

Edan to Highlight Its New Developments at MEDICA 2019

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to ...

2019-11-19 18:18 1284

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHENYANG, China and BEDFORD Mass., Nov. 17, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX:1530) and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first lice...

2019-11-18 08:30 4200
1 ... 209210211212213